Umbilical cord blood mesenchymal stem cells application in hematopoietic stem cells expansion on nanofiber three‐dimensional scaffold. Issue 7 (25th February 2019)
- Record Type:
- Journal Article
- Title:
- Umbilical cord blood mesenchymal stem cells application in hematopoietic stem cells expansion on nanofiber three‐dimensional scaffold. Issue 7 (25th February 2019)
- Main Title:
- Umbilical cord blood mesenchymal stem cells application in hematopoietic stem cells expansion on nanofiber three‐dimensional scaffold
- Authors:
- Darvish, Maryam
Payandeh, Zahra
Soleimanifar, Fatemeh
Taheri, Behnaz
Soleimani, Masoud
Islami, Maryam - Abstract:
- Abstract: Umbilical cord blood (UCB) hematopoietic stem cells (HSCs) transplantation (HSCTs) is considered as a therapeutic strategy for malignant and nonmalignant hematologic disorders. Nevertheless, the low number of HSCs obtained from each unit of UCB can be a major challenge for using these cells in adults. In addition, UCB is a rich source of mesenchymal stem cells (MSCs) creating hopes for nonaggressive and painless treatment in tissue engineering compared with bone marrow MSCs. This study was designed to evaluate the effects of UCB‐MSCs application in UCB‐HSCs expansion on the nanoscaffold that mimics the cell's natural niche. To achieve this goal, after flow cytometry confirmation of isolated HSCs from UCB, they were expanded on three‐dimensional (3D) poly‐l ‐lactic acid (PLLA) scaffolds fabricated by electrospinning and two‐dimensional (2D)‐culture systems, such as (1) HSCs‐MSCs culturing on the scaffold, (2) HSCs culturing on the scaffold, (3) HSCs‐MSCs culturing on 2D, and (4) HSCs culturing on 2D. After 7 days, real‐time polymerase chain reaction (PCR) was performed to evaluate the CXCR4 gene expression in the mentioned groups. Moreover, for the next validation, the number of total HSCs, 3‐(4, 5‐dimethylthiazol‐2‐yl)‐2, 5 diphenyl tetrazolium bromide assay, scanning electron microscopy imaging, and colony‐forming unit assay were evaluated as well. The results of the study indicated that UCB‐MSCs interaction with HSCs in 3D‐culture systems led to the highestAbstract: Umbilical cord blood (UCB) hematopoietic stem cells (HSCs) transplantation (HSCTs) is considered as a therapeutic strategy for malignant and nonmalignant hematologic disorders. Nevertheless, the low number of HSCs obtained from each unit of UCB can be a major challenge for using these cells in adults. In addition, UCB is a rich source of mesenchymal stem cells (MSCs) creating hopes for nonaggressive and painless treatment in tissue engineering compared with bone marrow MSCs. This study was designed to evaluate the effects of UCB‐MSCs application in UCB‐HSCs expansion on the nanoscaffold that mimics the cell's natural niche. To achieve this goal, after flow cytometry confirmation of isolated HSCs from UCB, they were expanded on three‐dimensional (3D) poly‐l ‐lactic acid (PLLA) scaffolds fabricated by electrospinning and two‐dimensional (2D)‐culture systems, such as (1) HSCs‐MSCs culturing on the scaffold, (2) HSCs culturing on the scaffold, (3) HSCs‐MSCs culturing on 2D, and (4) HSCs culturing on 2D. After 7 days, real‐time polymerase chain reaction (PCR) was performed to evaluate the CXCR4 gene expression in the mentioned groups. Moreover, for the next validation, the number of total HSCs, 3‐(4, 5‐dimethylthiazol‐2‐yl)‐2, 5 diphenyl tetrazolium bromide assay, scanning electron microscopy imaging, and colony‐forming unit assay were evaluated as well. The results of the study indicated that UCB‐MSCs interaction with HSCs in 3D‐culture systems led to the highest expansion of UCB‐HSCs on day 7. Flow cytometry results showed the highest purity of HSCs cocultured with MSCs. Real‐time PCR showed a significant increase in gene expression of CXCR4 in the mentioned group. The highest viability and clonogenicity were detected in the mentioned group too. Considered together, our results suggest that UCB‐HSCs and MSCs coculturing on PLLA scaffold could provide a proper microenvironment that efficiently promotes UCB‐HSCs expansion and UCB‐MSCs can also be considered as a promising candidate for UCB‐HSCTs. Abstract : Umbilical cord blood mesenchymal stem cells serve as a supportive layer, with noninvasive and painless access, on hematopoietic stem cells' expansion on poly‐l ‐lactic acid nanoscaffold. … (more)
- Is Part Of:
- Journal of cellular biochemistry. Volume 120:Issue 7(2019)
- Journal:
- Journal of cellular biochemistry
- Issue:
- Volume 120:Issue 7(2019)
- Issue Display:
- Volume 120, Issue 7 (2019)
- Year:
- 2019
- Volume:
- 120
- Issue:
- 7
- Issue Sort Value:
- 2019-0120-0007-0000
- Page Start:
- 12018
- Page End:
- 12026
- Publication Date:
- 2019-02-25
- Subjects:
- biodegradable scaffold -- CD133+ cell -- hematopoietic stem cells -- mesenchymal stem cells -- poly‐l‐lactic acid -- transplantation -- umbilical cord blood
Cytochemistry -- Periodicals
572 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-4644 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/jcb.28487 ↗
- Languages:
- English
- ISSNs:
- 0730-2312
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4955.010000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26180.xml